Elisa Belli

Elisa Belli has extensive experience in pharmaceutical research and laboratory settings. Currently serving as a Research Associate at Merck Group since April 2024, Elisa previously contributed as a Research Assistant in the Cell team at WaveBreak from August 2021 to April 2024, focusing on the development of hiPSC-based models for neurodegenerative diseases, particularly tauopathies. Prior roles include Laboratory Technician at ABIOGEN PHARMA S.P.A. in early 2021, where Elisa was involved in regulatory alignment and documentation for promotional materials, and a student intern at Farmacia di Colline, gaining hands-on experience in pharmaceutical preparations and management. Educational qualifications include a degree in Pharmaceutical Chemistry and Technologies from Università di Pisa, complemented by a certification for pharmaceutical practice.